MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0007505
Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹41.39 Lakh
▲ 47% YoY
Net profit · FY 2024
₹25,212
Net margin 0.6%
EBITDA · FY 2024
₹1.47 Lakh
EBITDA margin 3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹9 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Glary Pharmaceuticals Private Limited
Data last updated:
Glary Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2007PTC033337.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilam Singh and Asha Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 422 D Manas Enclave, Lucknow, Uttar Pradesh, India – 226015.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.39 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹25,212 (net margin 0.6%) and EBITDA of ₹1.47 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹9 Lakh on record.
Glary Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0007505). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Glary Pharmaceuticals Private Limited
CIN U24233UP2007PTC033337
Registration Number 033337
Incorporation Date 22 May 2007
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0007505
Key People
Nilam Singh Director Asha Singh Director Recognitions & Rankings of Glary Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address422 D Manas Enclave, Lucknow, Uttar Pradesh, India – 226015
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Glary Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Glary Pharmaceuticals Private Limited
The main business activity of Glary Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Glary Pharmaceuticals Private Limited FY 2024 filings available
Glary Pharmaceuticals Private Limited reported revenue of ₹41.39 Lakh (up 47% YoY) for FY 2024.
Revenue · FY 2024
₹41.39 Lakh ▲ 47%
Net profit · FY 2024
₹25,212 margin 0.6%
EBITDA · FY 2024
₹1.47 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR) of Glary Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 9%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 2%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 47% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Glary Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.47 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25,212 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Glary Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glary Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilam Singh | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
| Asha Singh | Director | 20 Apr 2019 | 7 Years 6 Months | Current |
Peer Comparison of Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mialtus Pharmaceuticals Private Limited | ₹41.44 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Delhi, India |
| Him Pharmaceuticals Private Limited | ₹41.43 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Surat, Gujarat, India |
| Sribio Pharmaceuticals Private Limited | ₹41.43 Lakh (FY 2024) | •••• | •••• | 24.0% | •••• | Chennai, Tamil Nadu, India |
| Meditm Pharmaceuticals Private Limited | ₹41.41 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Pune, Maharashtra, India |
| Genomics Healthcare Private Limited | ₹41.41 Lakh (FY 2020) | •••• | •••• | 30.0% | •••• | Howrah, West Bengal, India |
| Glary Pharmaceuticals Private Limited this company | ₹41.39 Lakh (FY 2024) | •••• | •••• | 47.0% | •••• | Lucknow, Uttar Pradesh, India |
| Vetgold Pharmaceuticals Private Limited | ₹41.38 Lakh (FY 2025) | •••• | •••• | 73.0% | •••• | Aurangabad, Maharashtra, India |
| Nextgen Pharmaceutical and Formulations Private Limited | ₹41.35 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Indore, Madhya Pradesh, India |
| Unimartpharma Private Limited | ₹41.33 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Sarv Shakti Ayurvedic Pharmaceuticals Private Limited | ₹41.25 Lakh (FY 2016) | •••• | •••• | 13.0% | •••• | Amritsar, Punjab, India |
| Zynext Pharmaceuticals Private Limited | ₹41.23 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Glary Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals Private Limited is audited by R J C P SUBHASH MISRA & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R J C P SUBHASH MISRA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Glary Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Glary Pharmaceuticals Private Limited
Open charges
₹9 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jun 2014 | Allahabad Bank | ₹9 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Glary Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Glary Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Asha Singh was appointed as Director on 20 Apr 2019.
AGM
Glary Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Glary Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Appointed
Asha Singh was appointed as Director.
Ceased
Rakesh Kumar Singh ceased to be Director.
Ceased
Nilam Singh ceased to be Additional Director.
Ceased
Munish Kumar Mishra ceased to be Director.
Appointed
Nilam Singh was appointed as Director.
Charges
A charge with Allahabad Bank amounted to Rs. 9.00 Lakh with Charge ID 10515868 was registered on 12 Jun 2014.
Incorporation
22 May 2007
Glary Pharmaceuticals Private Limited was registered on 22 May 2007 with Roc Kanpur & aged 19 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Glary Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glary Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glary Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glary Pharmaceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glary Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 May 2007 (19+ years old) and is registered under CIN U24233UP2007PTC033337.
Glary Pharmaceuticals reported revenue of ₹41.39 Lakh for FY 2024 (up 47% YoY).
Glary Pharmaceuticals has 2 current directors:
- Nilam Singh - Director
- Asha Singh - Director
Glary Pharmaceuticals reported a net profit of ₹25,212 (net margin 0.6%) and EBITDA of ₹1.47 Lakh (EBITDA margin 3.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Glary Pharmaceuticals is 9% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 47%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Glary Pharmaceuticals is U24233UP2007PTC033337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glary Pharmaceuticals was incorporated on 22 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Glary Pharmaceuticals by revenue are Mialtus Pharmaceuticals Private Limited, Him Pharmaceuticals Private Limited, Sribio Pharmaceuticals Private Limited, Meditm Pharmaceuticals Private Limited, Genomics Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Asha Singh was appointed as Director on 20 Apr 2019. Rakesh Kumar Singh ceased to be Director on 20 Apr 2019. Nilam Singh ceased to be Additional Director on 30 Sep 2015. Glary Pharmaceuticals has 5 board changes on record in total.
Yes, Glary Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0007505).
The registered office of Glary Pharmaceuticals is at 422 D Manas Enclave, Lucknow, Uttar Pradesh, India – 226015.